A detailed analysis of data from approximately 15,000 women undergoing cancer screening in the country found that women vaccinated against cervical cancer had a reduced risk of developing pre-cancer abnormalities. The research results were compiled by groups such as Osaka University.
This was compiled by a group such as Osaka University, and among the women aged 20 to 24 who underwent cancer screening for four years from 2013 in 31 municipalities nationwide with cooperation, the cervix We analyzed the data for a total of about 15,000 people, including about 2,500 people who were diagnosed with tissue abnormalities in the pre-stage of cancer and about 12,000 people who did not have any abnormalities.
Of these, about 3000 women were vaccinated against cervical cancer, and analysis showed that those who were vaccinated had mild tissue abnormalities that were pre-cancerous compared to those who were not vaccinated. The risk was about 58% lower.
In addition, the risk of moderate tissue abnormalities was approximately 75% lower.
In addition, eight people were diagnosed with cervical cancer, but none were vaccinated.
Dr. Sayaka Ikeda of the Graduate School of Medicine, Osaka University, who conducted the analysis, said, "I think that many people are worried about the cervical cancer vaccine, so it is important to accurately convey the scientific basis. I hope it helps you to make a decision about. "